PNL4 COMPARING THE RELATIVE COST-EFFECTIVENESS OF ORAL PROPHYLACTIC MEDICATION VS. BOTULINUM TOXIN TYPE A (BOTOX®) IN THE MANAGEMENT OF MIGRAINE HEADACHE- A MODEL EVALUATING THE CLINICAL AND ECONOMIC IMPACT OF CURRENT TREATMENT OPTIONS
Abstract
Authors
LD Goldberg